These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34070725)

  • 1. A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19.
    Costa B; Vale N
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34070725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review.
    Campbell CM; Guha A; Haque T; Neilan TG; Addison D
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32932930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Repurposing for Prevention and Treatment of COVID-19: A Clinical Landscape.
    Hossain MS; Hami I; Sawrav MSS; Rabbi MF; Saha O; Bahadur NM; Rahaman MM
    Discoveries (Craiova); 2020 Dec; 8(4):e121. PubMed ID: 33403227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.
    Alam S; Kamal TB; Sarker MMR; Zhou JR; Rahman SMA; Mohamed IN
    Front Pharmacol; 2021; 12():659577. PubMed ID: 34220503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review.
    Andrade BS; Rangel FS; Santos NO; Freitas ADS; Soares WRA; Siqueira S; Barh D; Góes-Neto A; Birbrair A; Azevedo VAC
    Front Pharmacol; 2020; 11():590598. PubMed ID: 33390967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19.
    Saha RP; Sharma AR; Singh MK; Samanta S; Bhakta S; Mandal S; Bhattacharya M; Lee SS; Chakraborty C
    Front Pharmacol; 2020; 11():1258. PubMed ID: 32973505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status of Baricitinib as a Repurposed Therapy for COVID-19.
    Saber-Ayad M; Hammoudeh S; Abu-Gharbieh E; Hamoudi R; Tarazi H; Al-Tel TH; Hamid Q
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Indari O; Jakhmola S; Manivannan E; Jha HC
    Front Pharmacol; 2021; 12():632677. PubMed ID: 33762954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data.
    Alakwaa FM
    mSystems; 2020 Apr; 5(2):. PubMed ID: 32291351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19.
    Saul S; Einav S
    ACS Infect Dis; 2020 Sep; 6(9):2304-2318. PubMed ID: 32687696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical challenges of clinical trials with a repurposed drug in outbreaks.
    Klas K; Strzebonska K; Waligora M
    Med Health Care Philos; 2023 Jun; 26(2):233-241. PubMed ID: 36881334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives.
    Kotta S; Aldawsari HM; Badr-Eldin SM; Alhakamy NA; Md S; Nair AB; Deb PK
    Front Mol Biosci; 2020; 7():606393. PubMed ID: 33282914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin: Potential Role as Repurposed Drug for COVID-19.
    Dixit A; Yadav R; Singh AV
    Malays J Med Sci; 2020 Jul; 27(4):154-158. PubMed ID: 32863755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comment] Treatment strategies to fight the new coronavirus SARS-CoV-2: A challenge for a Rubik's Cube solver.
    Tsitoura E; Bibaki E; Bolaki M; Vasarmidi E; Trachalaki A; Symvoulakis EK; Spandidos DA; Antoniou KM
    Exp Ther Med; 2020 Jul; 20(1):147-150. PubMed ID: 32536988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.
    Omolo CA; Soni N; Fasiku VO; Mackraj I; Govender T
    Eur J Pharmacol; 2020 Sep; 883():173348. PubMed ID: 32634438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19.
    Laws M; Surani YM; Hasan MM; Chen Y; Jin P; Al-Adhami T; Chowdhury M; Imran A; Psaltis I; Jamshidi S; Nahar KS; Rahman KM
    Curr Med Chem; 2021; 28(19):3803-3824. PubMed ID: 32693756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.